+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Xerostomia Therapeutics Market 2019-2023 - Product Image

Global Xerostomia Therapeutics Market 2019-2023

  • ID: 4721531
  • Report
  • Region: Global
  • 112 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Colgate-Palmolive
  • DAIICHI SANKYO
  • Eisai
  • GlaxoSmithKline
  • ORAHEALTH
  • MORE
The most common disease that causes xerostomia is an inflammatory autoimmune disease. Additionally, central nervous system-related diseases including stress, depression, and anxiety can also lead to xerostomia. Moreover, trauma to the head and neck area can alter the nerve stimuli to the mouth and impair the function to the salivary glands. Therefore, the rising incidence of the health conditions or diseases that are high-risk factors for xerostomia is expected to continue to support the growth of the global xerostomia therapeutics market during the forecast period. According to our industry experts, the xerostomia therapeutics market to grow at a CAGR of over 3% during the forecast period.

Market Overview

Growing geriatric population

The increasing number of people with xerostomia is directly related to the growing geriatric population. The number of old people worldwide has been growing significantly over the years. This expected to contribute significantly to the market as this high growth in the older population helps to drive the sales of various therapeutics markets during our forecast period.

Product recalls and tedious drug approval process

Regulatory bodies have framed stringent regulations to grant marketing approval for therapeutics that are being newly developed for the treatment of xerostomia. Many applications rejected either due to the inadequate performance of the drug or because the information on the drug, which is submitted is unsatisfactory. Such stringent government regulations can lead to a delay in drug in drug approval which in turn hampers the growth of the market.

For the detailed list of factors that will drive and challenge the growth of the xerostomia therapeutics market during the 2019-2023, view this report.

Competitive Landscape

The xerostomia therapeutics market is fragmented due to presence of many vendors in the market. The pharmaceutical companies are forming strategic collaborations which will enhance the R&D activities for new drugs for the management xerostomia. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Colgate-Palmolive
  • DAIICHI SANKYO
  • Eisai
  • GlaxoSmithKline
  • ORAHEALTH
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • OTC - Market size and forecast 2018-2023
  • Prescription - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DRIVERS AND CHALLENGES

PART 10: VENDOR LANDSCAPE
  • Market drivers
  • Market challenges
PART 11: TRENDS

PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Colgate-Palmolive
  • DAIICHI SANKYO
  • Eisai
  • GlaxoSmithKline
  • ORAHEALTH
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Years in consideration
Exhibit 02: Global oral hygiene products market
Exhibit 03: Segments of global oral hygiene products market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: OTC - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: OTC - Year-over-year growth 2019-2023 (%)
Exhibit 22: Prescription - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Prescription - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: Americas - Year-over-year growth 2019-2023 (%)
Exhibit 30: Top 3 countries in Americas
Exhibit 31: EMEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 33: Top 3 countries in EMEA
Exhibit 34: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 36: Top 3 countries in APAC
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Decision framework
Exhibit 40: Global prevalence of geriatric population
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Biologics under development for xerostomia
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Colgate-Palmolive - Vendor overview
Exhibit 49: Colgate-Palmolive - Business segments
Exhibit 50: Colgate-Palmolive - Organizational developments
Exhibit 51: Colgate-Palmolive - Geographic focus
Exhibit 52: Colgate-Palmolive - Segment focus
Exhibit 53: Colgate-Palmolive - Key offerings
Exhibit 54: Colgate-Palmolive - Key customers
Exhibit 55: DAIICHI SANKYO - Vendor overview
Exhibit 56: DAIICHI SANKYO - Organizational developments
Exhibit 57: DAIICHI SANKYO - Geographic focus
Exhibit 58: DAIICHI SANKYO - Key offerings
Exhibit 59: DAIICHI SANKYO - Key customers
Exhibit 60: Eisai - Vendor overview
Exhibit 61: Eisai - Business segments
Exhibit 62: Eisai - Organizational developments
Exhibit 63: Eisai - Geographic focus
Exhibit 64: Eisai - Segment focus
Exhibit 65: Eisai - Key offerings
Exhibit 66: Eisai - Key customers
Exhibit 67: GlaxoSmithKline - Vendor overview
Exhibit 68: GlaxoSmithKline - Business segments
Exhibit 69: GlaxoSmithKline - Organizational developments
Exhibit 70: GlaxoSmithKline - Geographic focus
Exhibit 71: GlaxoSmithKline - Segment focus
Exhibit 72: GlaxoSmithKline - Key offerings
Exhibit 73: GlaxoSmithKline - Key customers
Exhibit 74: ORAHEALTH - Vendor overview
Exhibit 75: ORAHEALTH - Organizational developments
Exhibit 76: ORAHEALTH - Key offerings
Exhibit 77: ORAHEALTH - Key customers
Exhibit 78: Validation techniques employed for market sizing
Exhibit 79: List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Colgate-Palmolive
  • DAIICHI SANKYO
  • Eisai
  • GlaxoSmithKline
  • ORAHEALTH
  • MORE
Global Xerostomia Therapeutics Market 2019-2023

The analyst recognizes the following companies as the key players in the global xerostomia therapeutics market: Colgate-Palmolive, DAIICHI SANKYO, Eisai, GlaxoSmithKline, ORAHEALTH.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the strategic alliances are expected to support the growth of the global xerostomia therapeutics market during our forecast period.”

According to the report, one of the major drivers for this market is the rising incidence of the health conditions or diseases that are high- risk factors for xerostomia is expected to continue to support the growth of the market during our forecast period.

Further, the report states that one of the major factors hindering the growth of this market is the stringent regulations to obtain marketing approval as well as recalls of drugs for the treatment of xerostomia are expected to hamper the growth of the market during our forecast period.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Colgate-Palmolive
  • DAIICHI SANKYO
  • Eisai
  • GlaxoSmithKline
  • ORAHEALTH
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4721531
Adroll
adroll